Lombard Medical Technologies keeps the blood flowing through your veins with its cardiovascular medical devices. The company's flagship product is Aorfix, an endovascular stent graft approved in the European Union for treatment of abdominal aortic aneurysms (balloon-like enlargements of the aorta in the abdomen). It is also pursuing approval in the US for the device. Additionally, the company is developing a stent graft to treat thoracic aortic aneurysms, which occur in the chest. Other products include EndoRefix, a patented endovascular stapling device used to attach stent grafts during surgery. Lombard Medical was founded in 2000.

KeyMed (Medical & Industrial Equipment) Ltd. is a key player when it comes to medical and industrial product distribution. A subsidiary of Japan's Olympus Corporation, KeyMed primarily makes endoscopic instruments to explore either the human body or the innards of industrial/electronic equipment. KeyMed is also the UK service-center location and exclusive distributor of Olympus' flexible and rigid endoscopes in Great Britain. The company's customers include hospitals, physician offices, and other health care settings, such as ambulatory surgical centers throughout the UK. The firm has branch offices in Scotland and Cheshire, and also distributes products in the US through subsidiary Olympus Industrial America.

Miami Children's Hospital not-for-profit medical center has nearly 300 beds and offers more than 40 different health care specialties, including pediatric emergency care, cancer treatment, orthopedics, and rehabilitation services. The hospital's neonatal unit treats newborns referred from other hospitals. Miami Children's Hospital has a staff of some 650 physicians and operates the region's only free-standing pediatric trauma center. The hospital first opened its doors in the 1940s as Miami Tent #33 of Variety Clubs International. Variety Children's Hospital opened in 1950 and became Miami Children's Hospital in 1986.

Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Medi-Jector Vision for insulin; Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Vibex pressure assisted auto injector platform that enables a controlled pressure delivery of drugs into the body utilizing a spring power source; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. Antares Pharma also develops/commercializes Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder; Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction; Nestorone contraceptive formulation products, which has completed Phase II clinical trials; and Ropinerole to treat a central nervous system. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements primarily with Teva Pharmaceutical Industries, Ltd.; BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Population Council, Ferring Pharmaceuticals BV; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV, as well as a strategic alliance with Uman Pharma. Antares Pharma, Inc. was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is based in Ewing, New Jersey.

MEDTOX is a full service laboratory, committed to providing clients with the services and solutions they need to run successful testing programs. For 25 years we have continually added new assays, support programs, new products and full laboratory divisions to meet the needs of our clients. MEDTOX services include.

Group Health Incorporated (GHI) is a not-for-profit health benefits company that provides managed health care coverage and related services to some 2.1 million members in New York State. Established in 1937, the company offers a wide range of medical, dental, and prescription drug plans to individuals, businesses, and government agencies. For businesses, it provides fully insured coverage or administrative services for self-insured employers. The firm also provides Medicare Advantage plans and manages care for recipients of Medicaid and other state-sponsored programs in some counties. Along with affiliate Health Insurance Plan of Greater New York (HIP), GHI is part of EmblemHealth.

Eger Health Care Center was founded in 1916 and is affiliated the Evangelical Lutheran Church in America. Eger Health Care Center provides hospice care, residential sub-acute care, specialized nursing services for the chronically ill, and adult day care services to the elderly and persons with disabilities. Edger Health Care Center also operates an on-site assisted living facility with about 75 beds.

Pro-Dex, Inc. engages in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control, and fractional horsepower DC motors. The company primarily designs, develops, and manufactures rotary drive systems for the medical device and dental industries. It sells various types of private label rotary drive systems for use in dental procedures, as well as cranial, spinal, arthroscopic, and orthopedic surgery. Pro-Dex also designs and manufactures miniature pneumatic motors, fractional horsepower DC motors, and motion control systems for industrial applications in the semi-conductor, automotive, aerospace, and apparel industries. In addition, it offers dental products primarily to original equipment manufacturers and dental product distributors. Further, the company manufactures and supplies embedded multi-axis motion controllers used to regulate the motion of servo and stepper motors for the factory automation, scientific research, and medical analysis equipment industries. Pro-Dex markets its products to hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities, and high tech manufacturing operations worldwide. The company was founded in 1978 and is headquartered in Irvine, California.

Rotech Healthcare Inc., together with its subsidiaries, provides home medical equipment and related products and services in the United States. It rents and sells oxygen and other respiratory therapy equipment and services, including oxygen concentrators, liquid oxygen systems, high pressure oxygen cylinders, homefill systems, portable oxygen concentrators, continuous positive airway pressure devices and supplies, bi-level positive airway pressure devices and supplies, non-invasive positive pressure ventilator devices and supplies, and nebulizer devices and medications. The company also sells and rents a line of durable medical equipment, such as hospital beds, wheelchairs, walkers, patient aids, and other ancillary supplies. Its patient service technicians or clinicians provide instruction and training to the patient and the patient’s family regarding equipment use and maintenance for the prescribed therapy. In addition, the company’s activities include reimbursement by third-party payors comprising Medicare, Medicaid, the Veterans Administration, and private insurers. Rotech Healthcare Inc. serves older patients with breathing disorders, such as chronic obstructive pulmonary diseases, which include chronic bronchitis, emphysema, obstructive sleep apnea, and other cardiopulmonary disorders. As of December 31, 2009, it had approximately 450 operating locations located primarily in non-urban markets in 48 states. Rotech Healthcare Inc. was founded in 1981 and is headquartered in Orlando, Florida.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. DexCom, Inc. also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet’s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.